Strategic Alliance & Business Development Manager

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 13, 2026

Salary

$129K-$193K From the posting source

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$57,704 U.S. median for this role

Projected growth (BLS Employment Projections)

+0.9% - Slower

U.S. benchmark only; posted salary is not compared across countries or currencies.

Matched to SOC 41-2031 - Sales aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Sales From the posting source

Seniority

Senior From the posting source

Work mode

Remote From the posting source

In-office days

0 days From the posting source

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Equity

Offered Verified - SEC 10-K source

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Strategic Alliance & Business Development Manager Remote (WFH) At Adaptive, we're Powering the Age of Immune Medicine. Our goal is to harness the power of the adaptive immune system to transform the way diseases are diagnosed and treated. As an Adapter, you'll have the opportunity to make a difference in people's lives. With Adaptive, you'll create a career highlight through collaboration with bright, curious colleagues working at the apex of innovation and application. It's time for your next chapter. Discover your story with Adaptive. Position Overview Adaptive has a growing Pharma MRD business, which includes a portfolio of more than 140 clinical trials under management. The Pharma MRD group engages with new and existing customers to incorporate the Adaptive NGS-based MRD Assay into studies to evaluate minimal residual disease (MRD) as a prognostic and predictive early biomarker of response to assess depth and duration of response to a variety of cancer therapies. The Adaptive NGS-based MRD Assay was granted de novo designation and marketing authorization by FDA (under Section 513(f)(2) of the Food, Drug and Cosmetic Act) in patients with multiple myeloma, acute lymphoblastic leukemia and chronic lymphocytic leukemia under the clonoSEQ® mark. The Strategic Alliance & Business Development Manager at Adaptive Biotechnologies plays a central role to support the expanding MRD pharma business. The MRD portfolio comprises of exploratory and regulated programs, including high impact, multi-year collaborations and translational partnerships with major biopharmaceutical and biotechnology companies. The Strategic Alliance & Business Development Manager is responsible for supporting and driving

Read the full description at www.adaptivebiotech.com. FewerJobs shows a preview and links to the original posting.